SCHEMBL7513124

SCHEMBL7513124

CCCSc1nc(NCCc2ccccc2)c2nnn([C@@H]3C[C@H](C(=O)O)[C@@H](O)[C@H]3O)c2n1

nearest known ligand 0.79

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ P2RY12 Q9H244 18/20 0.79
▸ PGR P06401 1/20 0.44
▸ ADORA3 P0DMS8 1/20 0.44
▸ CHRM1 P11229 1/20 0.44
▸ DRD1 P21728 1/20 0.44
▸ TBXA2R P21731 1/20 0.44
▸ PTGS1 P23219 1/20 0.44
▸ SLC6A2 P23975 1/20 0.44
▸ FPR3 P25089 1/20 0.44
▸ PDE4A P27815 1/20 0.44
▸ GPR183 P32249 1/20 0.44
▸ DRD3 P35462 1/20 0.44
▸ SLC6A3 Q01959 1/20 0.44
▸ KCNH2 Q12809 1/20 0.44
▸ PDE3A Q14432 1/20 0.44
▸ TMEM97 Q5BJF2 1/20 0.44
▸ SLC29A1 Q99808 1/20 0.44
▸ P2RY13 Q9BPV8 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7513131 1.00 P2RY12 (0.79) P2RY12PGRADORA3CHRM1DRD1
SCHEMBL7509019 0.94 P2RY12 (0.80) P2RY12PGRADORA3CHRM1DRD1
SCHEMBL7509010 0.94 P2RY12 (0.80) P2RY12PGRADORA3CHRM1DRD1
SCHEMBL7510491 0.94 P2RY12 (0.78) P2RY12PGRADORA3CHRM1DRD1
SCHEMBL7510483 0.94 P2RY12 (0.78) P2RY12PGRADORA3CHRM1DRD1
SCHEMBL7508912 0.93 P2RY12 (0.75) P2RY12PGRADORA3CHRM1DRD1
SCHEMBL7508901 0.93 P2RY12 (0.75) P2RY12PGRADORA3CHRM1DRD1
SCHEMBL6992268 0.92 P2RY12 (0.67) P2RY12PGRADORA3CHRM1DRD1
SCHEMBL6992270 0.92 P2RY12 (0.67) P2RY12PGRADORA3CHRM1DRD1
SCHEMBL7509938 0.91 P2RY12 (0.80) P2RY12PGRADORA3CHRM1DRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0946561-B1 TRIAZOLO(4,5-D)PYRIMIDINYL DERIVATIVES AND THEIR USE AS MEDICAMENTS ASTRAZENECA AB (SE) 2002-02-13 — — EP disclosed
US-6297232-B1 TREATMENT OF PLATELET AGGREGATION DISORDERS. ASTRAZENECA AB (SE) 2001-10-02 — — US disclosed
Send feedback